Vertex Pharmaceuticals Tax Reconciliation: Other Adjustments remained flat by 0.0% to $0.07 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 2436.4%, from $0.00 to $0.07. This increase may warrant attention — for this metric, lower values are generally preferred.
Large, frequent adjustments may signal unpredictable tax planning or complex regulatory exposure.
This represents miscellaneous items in the effective tax rate reconciliation that do not fall into standard categories l...
Commonly found in the 'other' line item of tax rate reconciliation tables for multinational corporations.
is_cat_tax_reconciliation_other_adjustments| FY'23 | FY'24 | |
|---|---|---|
| Value | $0.01 | $0.28 |
| YoY Change | — | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.